Boron-containing molecular sieve CHA

Details for Australian Patent Application No. 2005310231 (hide)

Owner Chevron U.S.A. Inc.

Inventors Yuen, Lun-Teh; Zones, Stacey I.

Agent Davies Collison Cave

Pub. Number AU-B-2005310231

PCT Pub. Number WO2006/060101

Priority 60/632,022 30.11.04 US; 60/632,008 30.11.04 US; 60/632,005 30.11.04 US; 60/632,007 30.11.04 US; 60/632,006 30.11.04 US

Filing date 2 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 3 March 2011

International Classifications

B01D 53/22 (2006.01) Separation of gases or vapours - by diffusion

B01D 53/56 (2006.01) Separation of gases or vapours - Nitrogen oxides

B01D 53/94 (2006.01) Separation of gases or vapours - by catalytic processes

B01D 59/12 (2006.01) Separation of different isotopes of the same chemical element

C01B 39/12 (2006.01) Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites

C01B 39/48 (2006.01) Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites

C07C 1/02 (2006.01) Hydrocarbons

C07C 1/20 (2006.01) Hydrocarbons

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/060101 Priority application(s): WO2006/060101

3 March 2011 Application Accepted

  Published as AU-B-2005310231

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005310238-N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators

2005310229-Crystallization method for benzphetamine